Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects

Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects

Jevtana<sup>®</sup> is a micellar cabazitaxel (CBZ) solution that was approved for prostate cancer in 2010, and recently, this drug has been reported for breast cancer. The purpose of this study is to evaluate the mediated delivery of CBZ via liposomes and nanoparticles (NPs) fo...

Full description

Bibliographic Details
Main Authors:	Nagavendra Kommineni, Shaheen Mahira, Abraham J. Domb, Wahid Khan
Format:	Article
Language:	English
Published:	MDPI AG 2019-03-01
Series:	Pharmaceutics
Subjects:	Jevtana<sup>®</sup> breast cancer cabazitaxel liposomes nanoparticles pharmacokinetics
Online Access:	https://www.mdpi.com/1999-4923/11/3/141

Similar Items

Cabazitaxel-induced stabilization of microtubules enhances radiosensitivity in ovarian cancer cells
by: Charles eKunos, et al.
Published: (2013-09-01)

Critical appraisal of cabazitaxel in the management of advanced prostate cancer
by: Sumanta Kumar Pal, et al.
Published: (2010-12-01)

Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer
by: Shaheen Mahira, et al.
Published: (2019-02-01)

Delivery of the Radionuclide <sup>131</sup>I Using Cationic Fusogenic Liposomes as Nanocarriers
by: Rejhana Kolašinac, et al.
Published: (2021-01-01)

The Preparation, Determination of a Flexible Complex Liposome Co-Loaded with Cabazitaxel and β-Elemene, and Animal Pharmacodynamics on Paclitaxel-Resistant Lung Adenocarcinoma
by: Yi-Ying Zeng, et al.
Published: (2019-04-01)

Preparation, Characterization, and In Vivo Pharmacokinetic Study of the Supercritical Fluid-Processed Liposomal Amphotericin B
by: Chang-baek Lim, et al.
Published: (2019-11-01)

Folate Receptor-Targeted Albumin Nanoparticles Based on Microfluidic Technology to Deliver Cabazitaxel
by: Fanchao Meng, et al.
Published: (2019-10-01)

Testosterone Diminishes Cabazitaxel Efficacy and Intratumoral Accumulation in a Prostate Cancer Xenograft Model
by: Lisanne Mout, et al.
Published: (2018-01-01)

Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer
by: Qu N, et al.
Published: (2016-07-01)

ESTIMATION OF TOXIC EFFECTS OF MEDICINAL PREPARATION OF CABAZITAXEL
by: O. I. Avdeeva, et al.
Published: (2019-01-01)

CT findings in patients with Cabazitaxel induced pelvic pain and haematuria: a case series
by: Geethal N. Malalagama, et al.
Published: (2017-06-01)

Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy
by: Sun Y, et al.
Published: (2018-12-01)

Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer
by: Johann de Bono, et al.
Published: (2016-03-01)

Hydroxyapatite and Titanium Dioxide Nanoparticles: Radiolabelling and In Vitro Stability of Prospective Theranostic Nanocarriers for <sup>223</sup>Ra and <sup>99m</sup>Tc
by: Petra Suchánková, et al.
Published: (2020-08-01)

Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles
by: Yougan Chen, et al.
Published: (2020-07-01)

Pharmacokinetics of Sativex<sup>®</sup> in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders
by: María Fernández-Trapero, et al.
Published: (2020-02-01)

Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer
by: Gianpaolo Perletti
Published: (2016-03-01)

Trans-Resveratrol Oral Bioavailability in Humans Using LipiSperse™ Dispersion Technology
by: David Briskey, et al.
Published: (2020-12-01)

Retreatment with cabazitaxel in a long-surviving patient with castration-resistant prostate cancer and visceral metastasis
by: Raquel Luque Caro, et al.
Published: (2018-01-01)

Evaluation of Nanotargeted <sup>111</sup>In-Cyclic RGDfK-Liposome in a Human Melanoma Xenotransplantation Model
by: Si-Yen Liu, et al.
Published: (2021-01-01)

Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations
by: Patel SA, et al.
Published: (2017-08-01)

Sequencing of Cabazitaxel in Metastatic Castrate-Resistant Prostate Cancer: A Case Report
by: Donald Colbourn
Published: (2012-06-01)

Compatible Stability and Aerosol Characteristics of Atrovent<sup>®</sup> (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine
by: Yiting Chen, et al.
Published: (2020-08-01)

Pleuropulmonary and Lymph Node Progression after Docetaxel - Benefits from Treatment with Cabazitaxel in Metastatic Prostate Cancer
by: Angel Segura Huerta, et al.
Published: (2013-07-01)

Cabazitaxel in the treatment of castration-resistant cancer: hitting the balance of efficacy and safety
by: M. I. Volkova, et al.
Published: (2019-06-01)

Influence of Individual Ions on Silica Nanoparticles Interaction with Berea Sandstone Minerals
by: Aly A. Hamouda, et al.
Published: (2019-09-01)

Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology
by: Amelia-Naomi Sabo, et al.
Published: (2021-03-01)

Ca<sup>2+</sup> Signaling as the Untact Mode during Signaling in Metastatic Breast Cancer
by: Dongun Lee, et al.
Published: (2021-03-01)

Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated <sup>188</sup>Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor
by: Bing-Ze Lin, et al.
Published: (2020-08-01)

Eudragit S100 Entrapped Liposome for Curcumin Delivery: Anti-Oxidative Effect in Caco-2 Cells
by: Vincenzo De Leo, et al.
Published: (2020-01-01)

The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients
by: Naoki Terada, et al.
Published: (2019-02-01)

Role of Intracellular Na<sup>+</sup> in the Regulation of [Ca<sup>2+</sup>]<sub>i</sub> in the Rat Suprachiasmatic Nucleus Neurons
by: Ruo-Ciao Cheng, et al.
Published: (2019-09-01)

TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
by: Yohei Sekino, et al.
Published: (2019-08-01)

Physicochemical, Pharmacokinetic, and Toxicity Evaluation of Soluplus<sup>®</sup> Polymeric Micelles Encapsulating Fenbendazole
by: Ik Sup Jin, et al.
Published: (2020-10-01)

Matrix Metalloproteinase-11 Promotes Early Mouse Mammary Gland Tumor Growth through Metabolic Reprogramming and Increased IGF1/AKT/FoxO1 Signaling Pathway, Enhanced ER Stress and Alteration in Mitochondrial UPR
by: Bing Tan, et al.
Published: (2020-08-01)

The NUNAtak Ice Thinning (NUNAIT) Calculator for Cosmonuclide Elevation Profiles
by: Ángel Rodés
Published: (2021-08-01)

Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre
by: Vanita Noronha, et al.
Published: (2016-08-01)

Hypoxic enhancement of exosome release by breast cancer cells
by: King Hamish W, et al.
Published: (2012-09-01)

Live-Cell Imaging of Physiologically Relevant Metal Ions Using Genetically Encoded FRET-Based Probes
by: Helmut Bischof, et al.
Published: (2019-05-01)

Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study
by: Takashi Matsumoto, et al.
Published: (2021-06-01)